This information was published on 2026-01-09T08:37:30 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2611204 (IR 1890312) |
| (220) |
06 Nov 2025
|
| (300) |
US, 19 May 2025, 99192492
|
| (511) (510) |
Class 5
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. |
| (540) | NELKARMI |
| (550) | Word |
| (730) |
Nuvalent, Inc.
|
Find out more about publications on the About page.